Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liprotamase vs Pancrelipase in CF-related EPI (SOLUTION)
NCT02279498Phase 3Completed
- Sponsor
- Anthera Pharmaceuticals, Inc.
- Start
- Jun 2015
- Primary completion
- Oct 2016
- Modality
- Replacement Enzymes
- Countries
- 7
01
Overview
A Phase 3 trial of liprotamase in exocrine pancreatic insufficiency (EPI), sponsored by Anthera Pharmaceuticals, Inc.. Started Jun 2015; status: completed.
02
Drugs
liprotamase
03
Conditions
exocrine pancreatic insufficiency (EPI)
Beyond the preview
Go deeper on NCT02279498.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02279498.